{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T04:52:40Z","timestamp":1754110360761,"version":"3.37.3"},"reference-count":40,"publisher":"European Respiratory Society (ERS)","issue":"2","funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2012\/07B\/NZ6\/03536"],"award-info":[{"award-number":["2012\/07B\/NZ6\/03536"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004965","name":"Sixth Framework Programme","doi-asserted-by":"publisher","award":["INCA LSHC-CT-2005-018704"],"award-info":[{"award-number":["INCA LSHC-CT-2005-018704"]}],"id":[{"id":"10.13039\/501100004965","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002910","name":"F\u00e9d\u00e9ration Wallonie-Bruxelles","doi-asserted-by":"publisher","award":["Action de Recherche Concert\u00e9e Glyvir"],"award-info":[{"award-number":["Action de Recherche Concert\u00e9e Glyvir"]}],"id":[{"id":"10.13039\/501100002910","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["Lung cancer"],"award-info":[{"award-number":["Lung cancer"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002749","name":"Federaal Wetenschapsbeleid","doi-asserted-by":"publisher","award":["Interuniversity Attraction Poles programme BELVIR"],"award-info":[{"award-number":["Interuniversity Attraction Poles programme BELVIR"]}],"id":[{"id":"10.13039\/501100002749","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2015,8,24]]},"published-print":{"date-parts":[[2015,10]]},"abstract":"<jats:p>With 5-year survival rates below 5%, small cell lung carcinoma (SCLC) has very poor prognosis and requires improved therapies. Despite an excellent overall response to first-line therapy, relapses are frequent and further treatments are disappointing. The goal of the study was to improve second-line therapy of SCLC.<\/jats:p><jats:p>The effect of chemotherapeutic agents was evaluated in cell lines (apoptosis, reactive oxygen species, and RNA and protein expression) and in mouse models (tumour development).<\/jats:p><jats:p>We demonstrate here that valproic acid, a histone deacetylase inhibitor, improves the efficacy of a second-line regimen (vindesine, doxorubicin and cyclophosphamide) in SCLC cells and in mouse models.<\/jats:p><jats:p>Transcriptomic profiling integrating microRNA and mRNA data identifies key signalling pathways in the response of SCLC cells to valproic acid, opening new prospects for improved therapies.<\/jats:p>","DOI":"10.1183\/23120541.00028-2015","type":"journal-article","created":{"date-parts":[[2015,10,20]],"date-time":"2015-10-20T04:30:16Z","timestamp":1445315416000},"page":"00028-2015","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Valproic acid improves second-line regimen of small cell lung carcinoma in preclinical models"],"prefix":"10.1183","volume":"1","author":[{"given":"Roland","family":"Hubaux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Vandermeers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Philippe","family":"Cosse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Crisanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veena","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M.","family":"Albelda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"Mascaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Delvenne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascale","family":"Hubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Willems","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"81","published-online":{"date-parts":[[2015,10,19]]},"reference":[{"key":"2024101706104272000_1.2.00028-2015.1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28505"},{"key":"2024101706104272000_1.2.00028-2015.2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00105009"},{"key":"2024101706104272000_1.2.00028-2015.3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007835"},{"key":"2024101706104272000_1.2.00028-2015.4","doi-asserted-by":"publisher","DOI":"10.3816\/CLC.2008.n.042"},{"key":"2024101706104272000_1.2.00028-2015.5","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1183\/09031936.01.00266101","article-title":"Chemotherapy in small cell lung cancer","volume":"18","author":"Osterlind","year":"2001","journal-title":"Eur Respir J"},{"key":"2024101706104272000_1.2.00028-2015.6","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.05.00117504"},{"key":"2024101706104272000_1.2.00028-2015.7","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-013-2223-9"},{"key":"2024101706104272000_1.2.00028-2015.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2004.03.021"},{"key":"2024101706104272000_1.2.00028-2015.9","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-0135"},{"key":"2024101706104272000_1.2.00028-2015.10","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00081310"},{"key":"2024101706104272000_1.2.00028-2015.11","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00037310"},{"key":"2024101706104272000_1.2.00028-2015.12","doi-asserted-by":"publisher","DOI":"10.1016\/0301-0082(82)90010-7"},{"key":"2024101706104272000_1.2.00028-2015.13","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/00001813-199609000-00008","article-title":"Antitumor activity of sodium valproate in cultures of human neuroblastoma cells","volume":"7","author":"Cinatl","year":"1996","journal-title":"Anticancer Drugs"},{"key":"2024101706104272000_1.2.00028-2015.14","first-page":"25","article-title":"Pharmacokinetics, drug interactions, and tolerability of valproate","volume":"37: Suppl. 2","author":"DeVane","year":"2003","journal-title":"Psychopharmacol Bull"},{"key":"2024101706104272000_1.2.00028-2015.15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07426.x"},{"key":"2024101706104272000_1.2.00028-2015.16","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-09-0138"},{"key":"2024101706104272000_1.2.00028-2015.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2007.11.003"},{"key":"2024101706104272000_1.2.00028-2015.18","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/20.24.6969"},{"key":"2024101706104272000_1.2.00028-2015.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2010.03.021"},{"key":"2024101706104272000_1.2.00028-2015.20","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-1579"},{"key":"2024101706104272000_1.2.00028-2015.21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0504248102"},{"key":"2024101706104272000_1.2.00028-2015.22","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e318298762f"},{"key":"2024101706104272000_1.2.00028-2015.23","doi-asserted-by":"publisher","DOI":"10.1081\/CLT-100102388"},{"key":"2024101706104272000_1.2.00028-2015.24","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-3632"},{"key":"2024101706104272000_1.2.00028-2015.25","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2013.00258"},{"key":"2024101706104272000_1.2.00028-2015.26","doi-asserted-by":"crossref","unstructured":"Berghmans T , Lafitte J-J , Scherpereel A , et al. VAC chemotherapy with valproic acid for refractory\/relapsing small cell lung cancer: a phase II study. ERJ Open Res 2015; 1: 00029-2015.","DOI":"10.1183\/23120541.00029-2015"},{"key":"2024101706104272000_1.2.00028-2015.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2009.11.006"},{"key":"2024101706104272000_1.2.00028-2015.28","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E08-11-1109"},{"key":"2024101706104272000_1.2.00028-2015.29","doi-asserted-by":"crossref","first-page":"673096","DOI":"10.1155\/2012\/673096","article-title":"miRNA589 regulates epithelial-mesenchymal transition in human peritoneal mesothelial cells","volume":"2012","author":"Zhang","year":"2012","journal-title":"J Biomed Biotechnol"},{"key":"2024101706104272000_1.2.00028-2015.30","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.febslet.2015.02.013","article-title":"MicroRNA-575 targets BLID to promote growth and invasion of non-small cell lung cancer cells","volume":"589","author":"Wang","year":"2015","journal-title":"FEBS Lett"},{"key":"2024101706104272000_1.2.00028-2015.31","doi-asserted-by":"publisher","DOI":"10.1038\/nature03147"},{"key":"2024101706104272000_1.2.00028-2015.32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.17.10164"},{"key":"2024101706104272000_1.2.00028-2015.33","doi-asserted-by":"publisher","DOI":"10.1593\/neo.08320"},{"key":"2024101706104272000_1.2.00028-2015.34","doi-asserted-by":"crossref","unstructured":"Hubaux R , Thu KL , Lam WL . Re: the Wnt signaling pathway in non-small cell lung cancer. J Natl Cancer Inst 2014; 106.","DOI":"10.1093\/jnci\/dju188"},{"key":"2024101706104272000_1.2.00028-2015.35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.23.12776"},{"key":"2024101706104272000_1.2.00028-2015.36","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603167"},{"key":"2024101706104272000_1.2.00028-2015.37","first-page":"A5539","article-title":"The tumor suppressor role of Wnt\/\u03b2-catenin pathway in small cell lung cancer","volume":"185","author":"Park","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101706104272000_1.2.00028-2015.38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3727\/096504008784046108","article-title":"Hyperinduction of Wnt activity: a new paradigm for the treatment of colorectal cancer?","volume":"17","author":"Bordonaro","year":"2008","journal-title":"Oncol Res"},{"key":"2024101706104272000_1.2.00028-2015.39","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3419"},{"key":"2024101706104272000_1.2.00028-2015.40","doi-asserted-by":"publisher","DOI":"10.1002\/path.2628"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00028-2015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T04:52:51Z","timestamp":1740372771000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00028-2015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,10,19]]},"published-print":{"date-parts":[[2015,10]]}},"alternative-id":["10.1183\/23120541.00028-2015"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00028-2015","relation":{},"ISSN":["2312-0541"],"issn-type":[{"type":"electronic","value":"2312-0541"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}